ŌURA Unveils 2 New Features for Heart Health
ŌURA announced two new heart health features on Friday: one that estimates cardiovascular age and one that measures cardio capacity.
ŌURA announced two new heart health features on Friday: one that estimates cardiovascular age and one that measures cardio capacity.
Pharmaceutical companies use Feel Therapeutics’ technology to monitor the mental state of participants in clinical trials of behavioral medications. But the startup envisions its technology eventually also finding a place as a part of clinical care.
The TSX Venture Exchange has a strong history of helping early-stage health and life sciences companies raise patient capital for research and development.
Biolinq raked in $58 million in capital this week. The company is developing a wearable patch that uses electrochemical sensors to measure a person’s glucose levels from the intradermal space just beneath the surface of their skin.
Oura — a company selling a ring that tracks peoples’ biometrics — announced new partnerships with three providers of continuous glucose monitors: January, Supersapiens and Veri. These companies will now be receiving sleep scores and other biometric data from Oura so they can see how these measurements affect users’ glucose levels and overall health.
Wearables company Movano Health recently partnered with Novant Health to beta test its smart ring — which is designed for women — with the health system’s employees. The program is expected to prepare Movano for its first direct-to-consumer product launch in the first half of next year.
Cala Health recently published a post-market study showing that its wrist-based wearable to treat essential tremor effectively reduced patients' tremor power with no loss of effect over time. Most patients involved in the study reported improvement in daily activities, such as eating, drinking, texting and writing.
This eBook, in collaboration with Care Logistics, details how hospitals and health systems can facilitate more effective decision-making by operationalizing elevated awareness.
Among consumers, wearables are growing in popularity. But what can clinicians actually gain from the data the devices collect? Panelists at the Connected Health Conference in Boston weighed in.
This was but one of several pieces of news the Amsterdam-based technology company discussed Monday at HIMSS17.
While consumers dabble in the cool features and sleek user interface of their wearables, healthcare providers continue to ask one important question: Does this tsunami of patient-generated data ultimately belong in the medical record?
Dr. Dave Albert demonstrated the replacement Apple Watch wristband Friday at the USC Center for Body Computing conference in Los Angeles.
In an era of escalating healthcare costs and a growing preference for natural, holistic approaches to health, The Impact Brands emerges as a collective of diverse brands dedicated to supporting overall wellness through natural means.
Wearables are starting to pop up everywhere in medicine — except, perhaps, actual clinical settings. Even a staid organization like the American Psychiatric Association had some on hand at its 168th annual meeting this week, as this video illustrates.
Apparently some people have a difficult time determining whether or not their body odor is in the socially acceptable, non-offensive range. Or at least Google believes enough helpless stinkers are out there, and they could really use a little help. Google has been awarded a patent for a wearable “fragrance emission device” that not only […]
With personal injury cases, it’s difficult to determine whether or not someone deserves compensation when they can’t work. If someone is in a car accident and is injured as a result, it’s the subjective perspective of doctors that calls the shots. But this might be changing. A firm in Calgary, McLeod Law, is working on […]
While the mobile health market may still be in its infancy, the world of wearables is perhaps growing up faster. Close to 100 million wearable remote patient health monitoring devices will be shipped over the next five years, according to ABI Research, which says the market is ” boosted by growing interest and awareness about the benefits […]
Massachusetts-based Neurometrix just received 510(k) clearance from the Food and Drug Administration for over-the-counter use of its wearable gadget that treats chronic pain. The lightweight device, which is still under development and projected for commercial launch next year, emits electric jolts to the wearer. It is modeled after Sensus, the company’s device that treats pain associated with […]